BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11563997)

  • 1. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
    Hamilton MI; Sercombe J; Pounder RE
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo.
    Grimley CE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
    Aliment Pharmacol Ther; 1997 Oct; 11(5):881-5. PubMed ID: 9354196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
    Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
    Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: a comparative study with cimetidine and placebo.
    Grimley CE; Constantinides S; Snell CC; Mills JG; Nwokolo CU
    Aliment Pharmacol Ther; 1997 Oct; 11(5):875-9. PubMed ID: 9354195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The action of 10 mg famotidine versus 200 mg cimetidine: onset and magnitude of antisecretory action within the first 2 hours after administration.
    Decktor D; Houle JM; Pierce CH
    Am J Ther; 1998 Mar; 5(2):97-100. PubMed ID: 10099044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
    Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
    Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of low doses of ranitidine on intragastric acidity in healthy men.
    Wyeth JW; Pounder RE; Sercombe JC; Snell CC
    Aliment Pharmacol Ther; 1998 Mar; 12(3):255-61. PubMed ID: 9570260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric and esophageal acidity during continuous treatment with H2-antagonists in uncomplicated esophagitis.
    Fiorucci S; Santucci L; Perrone E; Abbritti F; Morelli A
    Scand J Gastroenterol; 1989 Aug; 24(6):671-7. PubMed ID: 2573143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo.
    Hamilton MI; Sercombe J; Pounder RE
    Dig Dis Sci; 2002 Jan; 47(1):54-7. PubMed ID: 11837732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
    Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
    Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
    Savarino V
    Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring.
    Celle G; Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P
    Scand J Gastroenterol; 1988 May; 23(4):385-90. PubMed ID: 2898167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single night-time dose of famotidine is equivalent to ranitidine in decreasing 24-hour gastric acidity in asymptomatic duodenal ulcer subjects.
    Thomson AB; Pinchbeck BR; Kirdeikis J; Zuk L; Marriage B; Prat A
    Aliment Pharmacol Ther; 1989 Apr; 3(2):199-210. PubMed ID: 2491470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the time of onset of action of ranitidine and famotidine on intra-gastric acidity.
    Gardner JD; Ciociola AA; Robinson M; McIsaac RL
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1317-26. PubMed ID: 12144582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric acid suppression is greater during intravenous ranitidine infusion versus bolus injections of famotidine.
    Hogan DL; McQuaid KR; Koss MA; Crombie DL; Hunter S; Metz C; Euler AR; Isenberg JI
    Aliment Pharmacol Ther; 1993 Oct; 7(5):537-41. PubMed ID: 8280822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trial.
    Reilly TG; Singh S; Cottrell J; Mann SG; Stauffer L; Walt RP
    Aliment Pharmacol Ther; 1996 Oct; 10(5):749-55. PubMed ID: 8899083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral famotidine on 24-hour intragastric acidity.
    Santana IA; Lanzon-Miller S; Pounder RE
    Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of gastric acidity with ranitidine or famotidine: early evening dosage is more effective than late evening dosage.
    Bauerfeind P; Cilluffo T; Emde C; Fimmel C; Kohler W; Gasser T; Blum AL
    Digestion; 1987; 37(4):217-22. PubMed ID: 2890546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of food intake on the antisecretory effect of low-dose ranitidine and famotidine.
    Netzer P; Eschenmoser K; Halter F; Inauen W
    Aliment Pharmacol Ther; 1999 Mar; 13(3):407-12. PubMed ID: 10102975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.